Synopsis
Synopsis
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Eurax
1. 483-63-6
2. N-ethyl-o-crotonotoluidide
3. Trans-crotamiton
4. Crotamitone
5. Eurax
6. Crotalgin
7. 124236-29-9
8. Veteusan
9. Crotamitex
10. Eurasil
11. Euraxil
12. Crotamitonum
13. Crotonyl-n-ethyl-o-toluidine
14. Crotamiton, (e)-
15. 2-butenamide, N-ethyl-n-(2-methylphenyl)-
16. (e)-n-ethyl-n-(2-methylphenyl)but-2-enamide
17. (e)-n-ethyl-n-(o-tolyl)but-2-enamide
18. O-crotonotoluidide, N-ethyl-
19. (2e)-n-ethyl-n-(2-methylphenyl)but-2-enamide
20. 2eeh27851y
21. 2-butenamide, N-ethyl-n-(2-methylphenyl)-, (e)-
22. Mfcd00026989
23. 2-butenamide, N-ethyl-n-(2-methylphenyl)-, (2e)-
24. Nsc-758951
25. Crotan
26. Caswell No. 431b
27. Bestloid
28. Crotamitonum [inn-latin]
29. Smr000059145
30. N-ethyl-n-(2-methylphenyl)but-2-enamide
31. Sr-01000759366
32. Einecs 207-596-3
33. Unii-d6s4o4xd0h
34. Epa Pesticide Chemical Code 055701
35. Chebi:31439
36. Brn 3275497
37. N-ethyl-n-(2-methylphenyl)-2-butenamide
38. Unii-2eeh27851y
39. Ai3-17732
40. N-crotonyl-n-ethyl-o-toluidine
41. (e)-crotamiton
42. Crotamiton [usp:inn:ban:jan]
43. Eurax (tn)
44. Prestwick2_000951
45. Prestwick3_000951
46. N-ethylcrotono-o-toluidide
47. N-ethyl-o-crotonotoluidine
48. G 7857
49. N-ethyl- O-crotonotoluidide
50. D6s4o4xd0h
51. Schembl32934
52. Bspbio_000942
53. Bspbio_002722
54. Crotamiton (jan/usp/inn)
55. 3-12-00-01856 (beilstein Handbook Reference)
56. Mls000759489
57. Mls001424003
58. Mls002222307
59. Mls002695895
60. N-ethyl-ortho-crotonotoluidide
61. Spectrum1505271
62. Bpbio1_001038
63. Component Of Eurax (salt/mix)
64. Chembl1200709
65. Gtpl11165
66. Zinc56427
67. N-ethyl-o-crotonotoluidide, 97%
68. Dtxsid101256463
69. Hms1570p04
70. Hms1922p21
71. Hms2051e10
72. Hms2090a10
73. Hms2093o12
74. Hms2097p04
75. Hms2234e16
76. Hms3714p04
77. Pharmakon1600-01505271
78. Bcp13315
79. Hy-b1177
80. N-ethyl-n-(o-tolyl)but-2-enamide
81. Nsc78382
82. Ccg-39402
83. Nsc-78382
84. Nsc758951
85. S1711
86. (e)-n-ethyl-n-o-tolylbut-2-enamide
87. Akos015892746
88. Cs-4730
89. Nc00107
90. Nsc 758951
91. Ncgc00094571-01
92. Ncgc00094571-02
93. Ncgc00094571-03
94. Ncgc00094571-04
95. Ncgc00094571-05
96. As-11641
97. Trans-n-ethyl-n-(o-tolyl)-2-butenamide
98. Sbi-0206763.p001
99. Ab00513973
100. E0814
101. N-ethyl-n-(2-methylphenyl)-2-butenamide #
102. D01381
103. D70888
104. (2e)-n-ethyl-n-(2-methylphenyl)-2-butenamide
105. Ab00513973-09
106. Ab00513973_10
107. 483c636
108. A827519
109. Q-200893
110. Q2439845
111. Sr-01000759366-4
112. Sr-01000759366-6
113. Brd-k13240564-001-01-8
114. Brd-k57179821-001-05-5
115. Brd-k57179821-001-08-9
116. Crotamiton, British Pharmacopoeia (bp) Reference Standard
117. Crotamiton, European Pharmacopoeia (ep) Reference Standard
118. Crotamiton, United States Pharmacopeia (usp) Reference Standard
119. N-ethyl-o-crotonotoluidide; Crotamitone; Crotalgin; Eurasil; Euraxil
Molecular Weight | 203.28 g/mol |
---|---|
Molecular Formula | C13H17NO |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Exact Mass | 203.131014166 g/mol |
Monoisotopic Mass | 203.131014166 g/mol |
Topological Polar Surface Area | 20.3 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 235 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Crotan |
PubMed Health | Crotamiton (On the skin) |
Drug Classes | Scabicide |
Drug Label | Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cety... |
Active Ingredient | Crotamiton |
Dosage Form | Lotion |
Route | Topical |
Strength | 10% |
Market Status | Prescription |
Company | Summers |
2 of 4 | |
---|---|
Drug Name | Eurax |
Active Ingredient | Crotamiton |
Dosage Form | Lotion; Cream |
Route | Topical |
Strength | 10% |
Market Status | Prescription |
Company | Ranbaxy |
3 of 4 | |
---|---|
Drug Name | Crotan |
PubMed Health | Crotamiton (On the skin) |
Drug Classes | Scabicide |
Drug Label | Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cety... |
Active Ingredient | Crotamiton |
Dosage Form | Lotion |
Route | Topical |
Strength | 10% |
Market Status | Prescription |
Company | Summers |
4 of 4 | |
---|---|
Drug Name | Eurax |
Active Ingredient | Crotamiton |
Dosage Form | Lotion; Cream |
Route | Topical |
Strength | 10% |
Market Status | Prescription |
Company | Ranbaxy |
Pesticides
Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Certificate Number : CEP 2014-260 - Rev 01
Issue Date : 2024-11-15
Type : Chemical
Substance Number : 1194
Status : Valid
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26374
Submission : 2012-08-29
Status : Active
Type : II
Registration Number : 228MF10116
Registrant's Address : No. 168 Kai-Yuan Rd. , Hsin-Ying Tainan City, 73055. Taiwan
Initial Date of Registration : 2016-06-21
Latest Date of Registration :
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2024-12-20
Registration Number : 20241031-211-J-1710(2)
Manufacturer Name : Syn-Tech Chem & Pharm. Co., Ltd.
Manufacturer Address : No. 168 Kai Yuan Rd., Hsin-Ying, Tainan City, 73055, Taiwan
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-11
Pay. Date : 2018-10-04
DMF Number : 33121
Submission : 2018-09-28
Status : Active
Type : II
Certificate Number : CEP 2018-095 - Rev 03
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 1194
Status : Valid
Available Reg Filing : CN |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11393
Submission : 1995-03-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15285
Submission : 2001-02-08
Status : Inactive
Type : II
Certificate Number : R1-CEP 1999-131 - Rev 03
Issue Date : 2012-05-11
Type : Chemical
Substance Number : 1194
Status : Withdrawn by Holder
Date of Issue : 2024-11-14
Valid Till : 2027-11-13
Written Confirmation Number : WC-0597
Address of the Firm :
Date of Issue : 2022-12-07
Valid Till : 2025-12-07
Written Confirmation Number : WC-0108
Address of the Firm :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4413
Submission : 1982-01-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
13 Apr 2024
Reply
30 May 2023
Reply
27 Dec 2022
Reply
30 Jul 2022
Reply
16 Feb 2022
Reply
24 Jan 2022
Reply
04 Jan 2022
Reply
25 Aug 2021
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
13
PharmaCompass offers a list of Crotamiton API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Crotamiton manufacturer or Crotamiton supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Crotamiton manufacturer or Crotamiton supplier.
PharmaCompass also assists you with knowing the Crotamiton API Price utilized in the formulation of products. Crotamiton API Price is not always fixed or binding as the Crotamiton Price is obtained through a variety of data sources. The Crotamiton Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Crotamitone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crotamitone, including repackagers and relabelers. The FDA regulates Crotamitone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crotamitone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Crotamitone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Crotamitone supplier is an individual or a company that provides Crotamitone active pharmaceutical ingredient (API) or Crotamitone finished formulations upon request. The Crotamitone suppliers may include Crotamitone API manufacturers, exporters, distributors and traders.
click here to find a list of Crotamitone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Crotamitone DMF (Drug Master File) is a document detailing the whole manufacturing process of Crotamitone active pharmaceutical ingredient (API) in detail. Different forms of Crotamitone DMFs exist exist since differing nations have different regulations, such as Crotamitone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Crotamitone DMF submitted to regulatory agencies in the US is known as a USDMF. Crotamitone USDMF includes data on Crotamitone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Crotamitone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Crotamitone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Crotamitone Drug Master File in Japan (Crotamitone JDMF) empowers Crotamitone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Crotamitone JDMF during the approval evaluation for pharmaceutical products. At the time of Crotamitone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Crotamitone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Crotamitone Drug Master File in Korea (Crotamitone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Crotamitone. The MFDS reviews the Crotamitone KDMF as part of the drug registration process and uses the information provided in the Crotamitone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Crotamitone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Crotamitone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Crotamitone suppliers with KDMF on PharmaCompass.
A Crotamitone CEP of the European Pharmacopoeia monograph is often referred to as a Crotamitone Certificate of Suitability (COS). The purpose of a Crotamitone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Crotamitone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Crotamitone to their clients by showing that a Crotamitone CEP has been issued for it. The manufacturer submits a Crotamitone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Crotamitone CEP holder for the record. Additionally, the data presented in the Crotamitone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Crotamitone DMF.
A Crotamitone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Crotamitone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Crotamitone suppliers with CEP (COS) on PharmaCompass.
A Crotamitone written confirmation (Crotamitone WC) is an official document issued by a regulatory agency to a Crotamitone manufacturer, verifying that the manufacturing facility of a Crotamitone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Crotamitone APIs or Crotamitone finished pharmaceutical products to another nation, regulatory agencies frequently require a Crotamitone WC (written confirmation) as part of the regulatory process.
click here to find a list of Crotamitone suppliers with Written Confirmation (WC) on PharmaCompass.
Crotamitone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Crotamitone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Crotamitone GMP manufacturer or Crotamitone GMP API supplier for your needs.
A Crotamitone CoA (Certificate of Analysis) is a formal document that attests to Crotamitone's compliance with Crotamitone specifications and serves as a tool for batch-level quality control.
Crotamitone CoA mostly includes findings from lab analyses of a specific batch. For each Crotamitone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Crotamitone may be tested according to a variety of international standards, such as European Pharmacopoeia (Crotamitone EP), Crotamitone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crotamitone USP).